Top Tweets for #CONY2024
At #CONy2024 in London, ADI CEO Paola Barbarino spoke on the vital importance of both international governmental organisations and national governments to address treatment access issues for those living with #dementia and Alzheimer’s disease. She highlighted a critical issue that many health ministers worldwide do not fully understand the impact of dementia within their countries, a disconnection that can have severe implications to the mental health of people living with dementia and their carers.
ADI calls on both international bodies and national governments to make dementia a health priority. More than ever, we need policy makers to step up and ensure that those affected by dementia receive the care they need.
https://t.co/n1tWZdWDuW
#DementiaPolicy #TimeToActOnDementia #WhatsYourPlan #ADI
Want to hear about the key components of rapidly progressive dementia (RPD) assessment? 🤔
Michael Geschwind of @UCSFmac shares details in a recent interview:
👉 https://t.co/Qz6ezE7d5P
#Dementia #Neurodegeneration #CONy2024 #NeuroTwitter #Neurology
Pituitary adenylate cyclase-activating is a neuropeptide implicated in a wide range of functions.
@alanrapoport (@UCLA) speaks on the potential of PACAP as a target in #Headache management: 👉 https://t.co/mFMbiYMsJJ
#Migraine #Neurology #Neuroscience #CONy2024 #ChronicMigraine
In a recent interview, @DrSanjay_B (@UCLIoN) highlights some of the ‘push and pull’ factors associated with the use of AI in medicine and #Neurology.
Click here to watch:
🎥 https://t.co/wcQ910Snb0
#NeuroTwitter #CONy2024
Precision medicine for #Parkinsons goes beyond targeted treatment & physicians must consider how best to personalize management based on individual needs.
@KRayChaudhuri1 (@KingsCollegeLon) discusses this further: 🎥 https://t.co/eRVCaanMH1
#CONy2024 #Neurology #NeuroTwitter
At #CONy2024, we caught up with @TonySchapira (@ucl) to hear about the launch of the new Phase III ASPro-PD study (Ambroxol to Slow Progression in Parkinson's Disease).
For details, watch our exclusive interview:
👉https://t.co/1U7M6bMkNE
#Neurology #NeuroTwitter #Parkinsons
Zvezdan Pirtošek comments on the debate he moderated at #CONy2024 over whether or not lecanemab should be extended beyond 18 months. Watch the full interview here
https://t.co/jRFgp2Hk7Q
Prof. @KlausSchmierer champions continued DMT use in MS at #CONy2024, arguing for ongoing treatment despite long-term stability of MS. His compelling research and experience highlights the necessity of DMTs, even older age, after 10 years of disease stability and 8+ years of treatment, only selective patients should discontinue dmt. #MultipleSclerosis #NeurologyDebates
@Florianadea vs GComi, is #multiplesclerosis progressive from outset #Cony2024 . I wonder who will be the winner?
#CONy2024 News: Lea Grinberg discusses sleep disturbance as a risk factor for Alzheimer’s disease in association with the accumulation of amyloid and tau proteins. Watch our video here. @grinberg_t @alzassociation
https://t.co/S1OUD1YsnS
Full house at #CONy2024 for a fascinating talk from Prof. Adam Zeman (@ZemanLab) on aphantasia – 'when all is dark in the mind’s eye'
Prof. Zeman has done a lot of research on the science of visual imagery, inc. the neural basis of visual imagination and its role in culture
People say that awe is critical to our well-being & this was certainly our daily dose!
@GavinGiovannoni debating about the role of EBV in ongoing MS disease activity at #Cony2024 conference
@KlausSchmierer debating against the notion that DMT should be discontinued after prolonged stability #Cony2024 conference
#CONy2024 | Really insightful debates in the #ALS space today
Dame Prof. Pam Shaw and Prof. Giancarlo Logroscino gave their thoughts on: 'The euphoria on personalized ALS/MND treatment with ASOs is premature'
⬆️ in NO votes from pre- to post-debate voting
#Neurology #MND
Debating controversial topics in #MultipleSclerosis at #CONy2024 today
Should DMTs be discontinued after prolonged stability?
Per Soelberg Sørensen argues YES vs Klaus Schmierer argues NO
Audience were split on this one. Before: 55% yes 45% no; After 43% yes 57% no!
@GavinGiovannoni arguing that EBV reactivation occurs in majority of cases of HSCT, but you cannot then explain the treatment effect of HSCT! Is EBV therefore the cause of MS?? #Cony2024
Blood-based biomarkers are useful for stratifying an individual’s early risk for #AlzheimersDisease but can they diagnose the disease? Read our story on the discussion between Robert Perneczky and Arfan Ikram at #CONy2024
https://t.co/U3J1qMvGrr
#CONy2024 News: Should we test all patients with subjective cognitive decline for biomarkers related to #AlzheimersDisease? Read our coverage of the debate between @DrPaulEdison and Zvezdan Pirtosek https://t.co/PrLc6oaCch
Last Seen Hashtags on Sotwe
mgai(***)()()filter:videos
minichatt
Seen from United States
เย็ดบนรถ
Seen from Thailand
minichatt(***) +filter:native_video
Seen from Brazil
anal japan
Seen from Turkey
minichatt(*******)(*****)(*****)********** filter:videos
Seen from Belgium
Mgai has:videos
Seen from United Kingdom
amateurorgy
Seen from United Kingdom
CMManoharLal
Seen from United States
thundr
Seen from Ireland
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers